<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">Finally, as far as type 2 diabetes mellitus (T2DM) is concerned, we now have to underline that, as recently pointed out by two Italian groups 
 <xref rid="b0075" ref-type="bibr">[15]</xref>, 
 <xref rid="b0095" ref-type="bibr">[19]</xref> and reported by Chinese scientists directly involved in the management of COVID-19 infection 
 <xref rid="b0100" ref-type="bibr">[20]</xref>, 
 <xref rid="b0105" ref-type="bibr">[21]</xref>, the disease is extremely frequent and associates with a higher mortality rate in hospitalized patients (
 <xref rid="t0015" ref-type="table">Table 3</xref> ) 
 <xref rid="b0110" ref-type="bibr">[22]</xref>. Such phenomenon, which was further confirmed in Italian patients by the most recent bulletin from the ISS, had become apparent, despite different prevalence estimates, since the very beginning of the epidemic in China 
 <xref rid="b0075" ref-type="bibr">[15]</xref>.
</p>
